Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
Details for 2013742568
Up to date per 16.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2013742568
Title / Product Name
5HT3-REZEPTORANTAGONISTEN
Status
Deleted
Protection Type
European Patent
(AT-) Application Number
2013742568
EP Publication Number
2875012
E-Number
1175161
Language
EN
PCT Number
US13050762
Publication Date
27.05.2015 A
04.09.2019 B1
Registration Date
04.09.2019
AT Publication Date
15.09.2019
Application Date
16.07.2013
Registration Number
-
Priorities
17.07.2012
US
201261672709 P
01.10.2012
US
201261708521 P
IPC
C07D 471/08 20060101AFI20190306BHEP
Maximum Duration of Protection
16.07.2033
Owner
Takeda Pharmaceutical Company Limited
1-1, Doshomachi 4-chome
Chuo-ku Osaka shi Osaka 541-0005
JP
Representative
No representatives present
Inventor
HITCHCOCK, Stephen
10410 Science Center Drive
San Diego, California 92121
US
MONENSCHEIN, Holdger
10410 Science Center Drive
San Diego, California 92121
US
REICHARD, Holly
10410 Science Center Drive
San Diego, California 92121
US
SUN, Huikai
10410 Science Center Drive
San Diego, California 92121
US
KIKUCHI, Shota
10410 Science Center Drive
San Diego, California 92121
US
MACKLIN, Todd
10410 Science Center Drive
San Diego, California 92121
US
HOPKINS, Maria
10410 Science Center Drive
San Diego, California 92121
US
see.ip - Details for 5HT3-REZEPTORANTAGONISTEN